The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2022

Filed:

Feb. 13, 2018
Applicants:

Guangzhou Bioseal Biotech Co. Ltd., Guangzhou Science, CN;

Ethicon, Inc., Somerville, NJ (US);

Inventors:

Shuang Chen, Guangzhou, CN;

Yufu Li, Somerville, NJ (US);

Aibin Yu, Shenzhen, CN;

Jianping Yu, Guangzhou, CN;

Assignees:

Guangzhou Bioseal Biotech Co. Ltd, Guangzhou Science, CN;

Ethicon, Inc., Raritan, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/36 (2006.01); A61K 38/48 (2006.01); A61K 31/717 (2006.01); A61K 9/16 (2006.01); A61P 11/00 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61L 24/10 (2006.01); A61L 24/08 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4833 (2013.01); A61K 9/007 (2013.01); A61K 9/06 (2013.01); A61K 9/16 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 9/1682 (2013.01); A61K 31/717 (2013.01); A61K 38/363 (2013.01); A61L 24/08 (2013.01); A61L 24/106 (2013.01); A61L 24/108 (2013.01); A61P 11/00 (2018.01); A61L 2400/04 (2013.01);
Abstract

The present invention is directed to hemostatic compositions comprising at least partially integrated agglomerated ORC fibers, fibrinogen, and thrombin and methods of forming a powdered hemostatic composition, comprising the steps of: forming a suspension of a mixture comprising particles of fibrinogen, thrombin, ORC fibers in a non-aqueous low boiling solvent, agitating and shearing said suspension in a high shear mixing reactor, adding water to allow particles to agglomerate, allowing the non-aqueous solvent to evaporate, drying and sieving the composition; and thus forming the powdered hemostatic composition.


Find Patent Forward Citations

Loading…